$VRTX mention timeline

Vertex Pharmaceuticals. Every tracked FinTwit mention of $VRTX, newest first. 14 mentions since the first on Aug 4, 2025. See the price chart.

July 2026 · 6 mentions

Jul 6
Adam Feuerstein ✡️ — $CRNX is a commercial stage biotech that was significantly underperforming the $XBI this year, similar to $INSM $MDGL $ALNY $BBIO Crinetics just acquired for a 100% premium by $V…↗
Jul 6
Adam Feuerstein ✡️ — $VRTX buying $CRNX $10B https://t.co/ikAEZdUjZw↗
Jul 5
Antonio Costa — $VRTX Good breakout last week. Buyable on a pullback to the pivot. https://t.co/FqzfvDEfD2↗
Jul 2
Adam Feuerstein ✡️ — Read here: A year after distressed buyout, what’s become of Bluebird Bio? CEO David Meek says the company, now called Genetix, is leading in sickle cell gene therapy $VRTX $CRSP…↗
Jul 2
Adam Feuerstein ✡️ — A year after distressed buyout, what’s become of Bluebird Bio? (Besides the new name, Genetix) Well... a lot, Genetix CEO David Meek told @Jasonmmast in a swaggering interview thi…↗
Jul 1
InvestmentGuru — While AI continues to dominate headlines, Biotechnology is quietly becoming one of the strongest sectors in the market. Top 15 Biotechnology Stocks to Watch: $VRTX – Leader in cys…↗

Jun 4
Adam Feuerstein ✡️ — Otsuka kidney drug slowed loss of function, but less than expected, in late-stage trial. Results leave room for competing treatments from $VERA $VRTX to perform better https://t.c…↗

Mar 12
Adam Feuerstein ✡️ — This week's Biotech Scorecard: Catching up on non-Prasad work. -- $ALDX is complaining about short sellers in the run-up to an FDA approval decision. Red flag! -- The $VRTX era o…↗
Mar 9
Adam Feuerstein ✡️ — Vertex $VRTX says its drug successfully reduced marker of kidney disease in late-stage trial https://t.co/TbEkcHVYBB via @Jasonmmast↗

Dec 22
KaizenInvestor — Biotech & Genomics is the 2nd largest growing TAM globally. Despite this potential, the sector remained stagnant in 2025. While capital flooded into AI, pharma was ignored. I expec…↗
Dec 6
Adam Feuerstein ✡️ — Hello! If you can break away from college football for a moment... #ASH25 Day One recap $SNDX Revuforj frontline AML results $VRTX $CRSP Casgevy in young kids Star Therapeutics…↗

Aug 21
Adam Feuerstein ✡️ — @sharkbiotech $ALNY is safe (no risk of blowing up) + lots of growth = a biotech stock generalists can own without worry. It's why I called $ALNY the new $VRTX↗
Aug 5
Adam Feuerstein ✡️ — From last night: Vertex $VRTX non-opioid pain franchise stumbles https://t.co/9rvPVrpBbC via @Jasonmmast @JonathanWosen↗
Aug 4
Adam Feuerstein ✡️ — $VRTX tonight good test of how much investors care about the pain franchise bc looks troubled after these updates.↗